Total antioxidant status in patients with obstructive sleep apnea without comorbidities: the role of the severity of the disease.
OBJECTIVE
Several studies suggest that obstructive sleep apnea syndrome (OSAS) is associated with oxidative stress. However, there are also contrary observations and the role of antioxidant mechanisms has not been fully explored.


METHODS
The present study evaluated serum total antioxidant status (TAS) in 32 OSAS patients without comorbidities, before and after a diagnostic sleep study and at a second sleep study after continuous positive airway pressure (CPAP) application.


RESULTS
Lower TAS values were found in the morning, immediately after the first sleep study, compared with those before sleep (1.68 ± 0.11 vs. 1.61 ± 0.10 mmol/l, p < 0.01); this was evident in patients with less severe syndrome [apnea-hypopnea index (AHI) <30; 1.73 ± 0.08 vs. 1.65 ± 0.09 mmol/l, p = 0.01] but not in severe syndrome (AHI ≥30; 1.64 ± 0.12 vs. 1.58 ± 0.10 mmol/l, p = 0.07). After CPAP application, a statistically significant decrease in TAS values was observed in patients with less severe syndrome (1.72 ± 0.05 vs. 1.63 ± 0.04 mmol/l, p = 0.003). On the contrary, no statistically significant changes in TAS were observed in patients with severe syndrome.


CONCLUSIONS
The present study supports a reduction in antioxidant capacity during sleep in otherwise healthy patients with OSAS. This reduction was evident in less severe syndrome. However, a single night of CPAP application seems to ameliorate this antioxidant disturbance only in less severe syndrome.
Pulmonary & Microbiology Department, General Army Hospital, Thessaloniki, Greece.
Kostas
K
Katsoulis
Theodore
T
Kontakiotis
Dimitris
D
Spanogiannis
Emmanouil
E
Vlachogiannis
Michalis
M
Kougioulis
Spyros
S
Gerou
Efimia
E
Daskalopoulou
D000328:Adult; D000975:Antioxidants / Q000378:metabolism*; D045422:Continuous Positive Airway Pressure; D006801:Humans; D008297:Male; D008875:Middle Aged; D018384:Oxidative Stress / Q000502:physiology*; D017286:Polysomnography; D012016:Reference Values; D020181:Sleep Apnea, Obstructive / Q000175:diagnosis* / Q000503:physiopathology* / Q000628:therapy
D000975:Antioxidants
Sleep. 1998 May 1;21(3):290-6
9595608
Sleep. 2004 Feb 1;27(1):123-8
14998248
Eur Respir J. 2000 Oct;16(4):644-7
11106206
Am J Med. 1991 Sep 30;91(3C):2S-13S
1928207
Eur Heart J. 2005 Nov;26(22):2435-9
16105851
Am J Physiol Regul Integr Comp Physiol. 2004 Aug;287(2):R284-7
15142836
Lancet. 1994 Sep 3;344(8923):653-5
7915351
Am J Respir Crit Care Med. 2002 Apr 1;165(7):934-9
11934717
Sleep. 1992 Apr;15(2):173-84
11032543
Clin Chim Acta. 2003 Jun;332(1-2):83-8
12763284
Sleep. 1999 Aug 1;22(5):667-89
10450601
Sleep Breath. 2005 Sep;9(3):119-26
15988615
Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):566-70
10934088
N Engl J Med. 1985 Jan 17;312(3):159-63
2981404
Sleep Med. 2009 Jan;10(1):87-94
18077211
Sleep Med. 2003 May;4(3):225-8
14592326
Eur Respir J. 2006 Apr;27(4):756-60
16585082